Program Description & Educational Objectives
In this two-part activity, experts in Alzheimer’s disease (AD) provide practical insight into the diagnosis and management of AD among minority patient populations. Topics of discussion include the identification of socioeconomic and medical risk factors for the development of AD, sociocultural and system barriers that may impede the diagnosis and institution of treatment, modified screening methods to improve the timely diagnosis of this disease, and an analysis of clinical trial data related to available therapies for the treatment of AD in minority patient populations.
Upon completion of this activity, participants should be better able to:
- Identify and describe the various factors that may increase the risk of developing Alzheimer’s disease (AD) among minority patient populations
- Summarize and discuss the sociocultural and professional barriers that contribute to delays in the screening, diagnosis, and treatment of AD in at-risk minority patient populations
- Propose and implement effective strategies to improve diagnosis rates among minority patient populations who are at risk for AD
- Assess and apply recent efficacy and safety data related to pharmacologic therapies for AD in order to develop appropriate treatment plans for AD in minority patient populations
Target Audience
This activity has been designed to meet the educational needs of long-term care medical directors, geriatricians, primary care physicians, neurologists, and other clinicians active in the management of patients at risk for Alzheimer’s disease.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: July 14, 2010 - July 13, 2011
Time to Complete: 30 minutes
Faculty & Disclosure
Course Director and Interviewee
Pierre Tariot, MD
Research Professor of Psychiatry
University of Arizona College of Medicine
Director, Memory Disorders Center
Banner Alzheimer’s Institute
Phoenix, Arizona
Pierre Tariot, MD,
currently has no financial interests/relationships or affiliations in relation to this activity.
Interviewee
Gary W. Small, MD
Parlow-Solomon Professor on Aging
Professor of Psychiatry & Biobehavioral Sciences
Director, UCLA Center on Aging
Director, Memory & Aging Research Center
Director, Geriatric Psychiatry Division
Semel Institute for Neuroscience & Human Behavior
David Geffen School of Medicine at UCLA
Los Angeles, California
Gary W. Small, MD,
has a financial interest/relationship or affiliation in the form of:
Consultant for Dakim, Inc., Eisai Inc.; Forest Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; and Siemens Corporation.
Speakers Bureau participant with Dakim, Inc., Eisai Inc.; Forest Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; and Siemens Corporation.
Shareholder in Dakim, Inc.
Advisory Board for Medivation, Inc.
Other Financial or Material Support from the International Psychogeriatric Association.
CME Reviewer
Carla J. Herman, MD, MPH
Chief, Division of Geriatrics
Department of Internal Medicine
UNM Center on Aging
University of New Mexico Health Sciences Center, School of Medicine
Albuquerque, New Mexico
Carla J. Herman, MD, MPH,
currently has no financial interests/relationships or affiliations in relation to this activity.
Content Director
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education, Inc.
Kirk A. Tacka, PhD,
currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education. The University of New Mexico Health Sciences Center, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of New Mexico Health Sciences Center, School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from 
